MedTrace Logo

Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome

NCT04170686 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2021-02-16

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to assess if a new self-help app for IBS is an acceptable and effective intervention for improving the overall quality of life in patients with Irritable Bowel Syndrome.

Conditions

  • Irritable Bowel Syndrome

Interventions

BEHAVIORAL

Zemedy App for Irritable Bowel Syndrome

The Zemedy App for irritable bowel syndrome is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.

Sponsors & Collaborators

Principal Investigators

  • Melissa G Hunt, PhD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-28
Primary Completion
2020-09-28
Completion
2020-09-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04170686 on ClinicalTrials.gov